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Purpose: The objective of this study was to analyze the histology of breast lesions 
categorized as Breast Imaging Reporting and Data System (BI-RADS) 4c or 5 breast 
lesions during the imaging evaluation, but diagnosed as benign during the histological 
evaluation. Materials and Methods: We retrospectively reviewed 71 breast lesions 
categorized as BI-RADS 4c or 5 during imaging study, but diagnosed as benign upon 
histological evaluation. Results: Breast lesions were classified into six groups upon 
histological analysis: intraductal papilloma (18 cases), inflammatory group (15 cases), 
fibroepithelial tumor (14 cases), clustered microcalcification (10 cases), minimal his-
tological alteration (10 cases), and adenosis (4 cases). Sclerosis and architectural com-
plexity were associated with most of the biopsies that were morphologically similar to 
malignancy. Conclusion: Among 71 cases categorized as 4c or 5 during the imaging 
study, but diagnosed as benign upon histological examination, intraductal papilloma 
was the most frequently identified histological lesion. These 71 cases exhibited histo-
logical characteristics of sclerosis and/or complex/complicated features that should be 
histologically differentiated from malignancy during evaluation.
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INTRODUCTION
Breast cancer is the most common cancer in women, the incidence of which con-
tinues to increase worldwide. Imaging screening has contributed to substantial re-
ductions in breast cancer mortality, resulting in an increased prevalence of benign 
biopsies statistically.1-4 Benign breast biopsies can be distressing, and therefore the 
correct interpretation of mammography and ultrasound (US) results for breast le-
sions is very important. The most commonly used interpretive criteria are drawn 
from the Breast Imaging Reporting and Data System (BI-RADS) recommended 
by the American College of Radiology.5 BI-RADS classifies breast lesions from 
categories 2 to 5 depending on imaging characteristics as a final assessment, and 
category 4 is further subdivided into 4a, 4b, and 4c. In general, lesions of category 
4 or category 5 are recommended for tissue biopsy. The percentages of cases diag-
nosed with breast cancer are 6% in category 4a, 15% in category 4b, 53% in cate-
gory 4c, and 91% in category 5,6 indicating that some benign breast lesions are ini-
tially wrongly interpreted as highly suspicious for malignancy. To our knowledge, 
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sy results that were originally classified as category 4c or 5 
were considered discordant lesions. Category 5 was defined 
for lesions with two or more major suspicious findings (ir-
regular shape, spiculated margin, and microcalcification),8 
and non-category 5 lesions with a probability of malignan-
cy greater than 80% were defined as category 4c.9 Discor-
dant lesions were recommended for excision. To generate the 
imaging descriptions for this study, one of the radiologists 
retrospectively reviewed all images according to the BI-
RADS lexicon.10 However, to prevent bias due to foreknowl-
edge of the benign pathological diagnoses, we used the BI-
RADS final assessment on the original radiology reports 
instead of re-categorizing the final assessment for the lesion.
Histologic examination
All histological specimens were embedded in paraffin after 
fixation with 10% buffered formalin, sectioned at 4 µm and 
stained with hematoxylin and eosin (H&E). The sections 
were examined by two pathologists (Koo JS and Kim D) us-
ing a light microscope. If needed, multiple serial sections 
were examined to detect microcalcification. Different results 
were discussed, and a consultation was made with a third pa-
thologist when a persistent discordance occurred. When dis-
crepancies between the pathological diagnosis of CNB and 
surgical excision were detected, the higher-level diagnosis 
was considered as the final diagnosis. For example, intra-
ductal papilloma (IP) was taken as the final diagnosis if the 
case was diagnosed as IP by CNB and fibrocystic change by 
subsequent surgical excision. Immunohistochemical staining 
with p63 (DAKO, Glostrup, Denmark, 1 : 50, 4A4), estrogen 
receptor (ER, Thermo Scientific, San Jose, CA, USA, 1 : 100, 
SP1), and cytokeratin 5/6 (DAKO, Glostrup, Denmark, 1 : 
100, D5/16B4) were performed if needed for diagnosis.
Statistical analysis   
Data were analyzed using Statistical Package for the Social 
Science (SPSS) software for Windows, version 12.0 (SPSS 
Inc., Chicago, IL, USA). Student’s t-test and Fisher’s exact 
test were used to analyze continuous and categorical vari-
ables, respectively. Statistical significance was assumed for 
p-values <0.05.
 
RESULTS
 
Radio-pathological features 
Seventy-one cases were classified by histological analysis 
no studies on the histological analysis of breast lesions cate-
gorized as being of moderate concern for malignancy or 
worse (category 4c or 5) on US, but diagnosed as benign on 
histological examination have been reported. The purpose of 
this study was to analyze the histology of breast lesions cate-
gorized as 4c or 5 based on imaging, but diagnosed as be-
nign on histological examination and to determine the impli-
cations thereof.
MATERIALS AND METHODS
　　　
Patient selection
We selected patients who had undergone breast US, breast 
core needle biopsy (CNB), and subsequent surgical excision 
between 2003 and 2010 and satisfied the following criteria 
for inclusion in the present study: 1) diagnosed as either BI-
RADS category 4c or category 5 upon imaging study, includ-
ing US and mammography (n=2385); 2) diagnosed as be-
nign upon both breast US-guided CNB and subsequent 
surgical excision; and 3) lacking atypical ductal hyperplasia 
(ADH) or atypical lobular hyperplasia. This study included 
a total of 71 cases, and the Institutioanl Review Board (IRB) 
of Severance Hospital approved this study.
Imaging study and biopsy protocol
Sonographically guided CNB was performed with a high-
resolution sonographic unit and a 7.5- or 12-MHz linear ar-
ray transducer (HDI 5000, Philips ATL; Logic 9, GE Health-
care, Bothell, WA, USA). All US imaging was performed 
by board-certificated and breast-dedicated radiologists, and 
the final assessment of each US examination combined 
with mammographic information was analyzed prospec-
tively by the same radiologists who performed the BI-
RADS category based examination prior to biopsy.7 For 
CNB, an automated gun (Pro-Mag 2.2, Manan Medical 
Products) and 14-gauge dual-action semiautomatic core bi-
opsy needles (Stericut with coaxial; TSK Laboratory, Toch-
igi, Japan) were used. At the same time, the maximal di-
mension of the lesion was measured by US. CNB was 
performed by the same radiologists who performed the US, 
and 4-5 samples were obtained for each patient according 
to the standard protocol of our institute. These samples 
were submitted to the pathology department for histological 
examination. For each lesion that underwent CNB, imag-
ing-histology correlations were reviewed at weekly confer-
ences and the breast lesions with benign pathological biop-
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most common lesion among the category 5 cases. The mean 
size of the breast lesions was 17.0±10.4 mm; the FET group 
had the largest mean size of 23.6±11.9 mm, and the adenosis 
group had the smallest mean size of 10.2±3.2 mm (p=0.057).
Upon examination, all cases exhibited suspicious imag-
ing findings, regardless of pathological grouping, indicative 
of 4c or 5 categorization. All 71 cases had non-circum-
into six groups: adenosis, clustered microcalcification (CMC), 
fibroepithelial tumor (FET), inflammatory group, intraductal 
papilloma (IP), and minimal histological alteration (MHA) 
(Table 1). Overall, IP was the most frequent diagnosis. There 
were 61 (85.9%) cases of category 4c lesions and 10 (14.1%) 
cases of category 5 lesions. IP was the most frequently identi-
fied lesion among the category 4c cases, and FET was the 
Table 1. Radiological Findings according to the Histological Groups of the 71 Cases of BI-RADS Category 4c or Category 5 
Benign Breast Lesions
Parameter 
Total
n=71 (%) 
Histological group
p valueAdenosis
n=4 (%)
CMC
n=10 (%)
FET
n=14 (%)
Inflammatory
n=15 (%)
IP
n=18 (%)
MHA
n=10 (%)
Mammographic finding* 0.001
    None 16 (25.8) 1 (6.3) 1 (6.3)   3 (18.8)   2 (12.5)   5 (31.3)   4 (25.0)
    Mass 31 (50.0) 2 (6.5) 1 (3.2)   9 (29.0)   8 (25.8)   6 (19.4)   5 (16.1)
    Calcification 12 (19.4) 0 (0.0)   8 (66.7) 0 (0.0) 1 (8.3)   2 (16.7) 1 (8.3)
    Mass and calcification 3 (4.8) 0 (0.0) 0 (0.0) 0 (0.0)   1 (33.3)   2 (66.7) 0 (0.0)
Ultrasonographic finding
    Shape 0.078
        Irregular 44 (62.0) 3 (6.8)   6 (13.6)   5 (11.4)   9 (20.5) 12 (27.3)   9 (20.5)
        Oval 20 (28.2) 0 (0.0)   2 (10.0)   9 (45.0)   4 (20.0)   4 (20.0) 1 (5.0)
        Round 7 (9.9)   1 (14.3)   2 (28.6) 0 (0.0)   2 (28.6)   2 (28.6) 0 (0.0)
   Orientation 0.487
        Not-parallel 41 (57.7) 4 (9.8) 4 (9.8)   8 (19.5)   8 (19.5) 11 (26.8)   6 (14.6)
        Parallel 30 (42.3) 0 (0.0)   6 (20.0)   6 (20.0)   7 (23.3)   7 (23.3)   4 (13.3)
    Margin 0.012
        Circumscribed 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0)
        Microlobulated 26 (36.6) 2 (7.7)   3 (11.5)   8 (30.8)   3 (11.5) 10 (38.5) 0 (0.0)
        Indistinct 14 (19.7) 0   3 (21.4)   4 (28.6)   5 (35.7) 0 (0.0)   2 (14.3)
        Angular 14 (19.7) 0 (0.0) 0 (0.0) 0 (0.0)   6 (42.8)   4 (28.6)   4 (28.6)
        Spiculated 17 (23.9)  2 (11.8)   4 (23.5)   2 (11.8) 1 (5.9)   4 (23.5)   4 (23.5)
Internal echogenicity 0.169
    Isoechoic 41 (59.1) 2 (4.9)   8 (19.5)   6 (14.6)   7 (17.1) 11 (26.8)   8 (19.5)
    Hypoechoic 29 (40.8) 2 (6.9) 2 (6.9)   8 (27.6)   8 (27.6)   7 (24.1) 2 (6.9)
Boundary 0.136
    Abrupt 46 (64.8) 3 (6.5)   9 (19.6) 11 (23.9)   6 (13.0) 11 (23.9)   6 (13.0)
    Echogenic halo 25 (35.2) 1 (4.0) 1 (4.0)   3 (12.0)   9 (36.0)   7 (28.0)   4 (16.0)
Posterior attenuation 0.066
    None 40 (56.3) 3 (7.5)   9 (22.5)   5 (12.5)   8 (20.0)   8 (20.0)   7 (17.5)
    Enhancement 17 (23.9) 0 (0.0) 0 (0.0)   6 (35.3)   3 (17.6)   8 (47.1) 0 (0.0)
    Shadowing 14 (19.7) 1 (7.1) 1 (7.1)   3 (21.4)   4 (28.6)   2 (14.3)   3 (21.4)
Microcalcification 0.006
    No 55 (77.5) 4 (7.3) 3 (5.5) 12 (21.8) 12 (21.8) 16 (29.1)   8 (14.5)
    Yes 16 (22.5) 0 (0.0)   7 (43.8)   2 (12.5)   3 (18.8)   2 (12.5)   2 (12.5)
Final assessment
    Category 4c 61 (85.9) 3 (4.9)   9 (14.7) 11 (18.0) 13 (21.3) 17 (27.9)   8 (13.1)
    Category 5 10 (14.1)   1 (10.0)   1 (10.0)   3 (30.0)   2 (20.0)   1 (10.0)   2 (20.0)
Size (mm, mean±SD) 17.0±10.4 10.2±3.2 11.5±4.9 23.6±11.9 16.6±6.3 13.1±5.3 18.5±16.1 0.057
CMC, clustered microcalcification; FET, fibroepithelial tumor; IP, intraductal papilloma; MHA, minimal histologic alteration; BI-RADS, Breast Imaging Re-
porting and Data System.
*Sixty-two mammograms were available for review.
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entrapped and distorted glands, as well as both lobules and 
ducts, with somewhat radial configurations (Fig. 1D). These 
2 cases were confirmed as benign lesions upon p63 stain-
ing, which revealed the presence of myoepithelial cells, and 
as UDH showed negativity for ER and positivity for CK5/6 
stain. Four cases were diagnosed as adenosis with two his-
tological characteristics. Two of these cases were sclerosing 
adenosis with glandular compression and distortion, ac-
companied by stromal proliferation, as the glands and tu-
bules increased (Fig. 2A). Among the 4 cases, 2 cases were 
confirmed as benign ducts/glands using immunohistochem-
istry for p63. The remaining 2 cases showed extensive in-
volvement of adenosis throughout the histological speci-
mens, indicating diffuse involvement (Fig. 2B). CMC was 
observed in 10 cases, presenting calcifications of variable 
sizes clustered into groups in the intraluminal spaces of 
glands or tubules. Among these 10 cases, 6 cases showed 
CMC in cysts or normal terminal duct-lobular units, and 4 
cases exhibited columnar cell change (Fig. 2C). In 5 cases, 
CMC was associated with ossifying-type calcification (OTC) 
that showed a central core of calcification with a rim of os-
sifying-type matrix (Fig. 2D). There were 14 cases with 
FET, nine with fibroadenoma and five with benign phyl-
lodes tumor. Fibroadenoma exhibited three histological 
characteristics. The first was a sclerotic stromal component, 
which was observed in 5 cases (Fig. 3A). The sclerotic stro-
mal component was observed throughout the whole lesion. 
Second, the epithelial component showed an intracanalicu-
lar pattern rather than a pericanalicular pattern in 5 cases 
(Fig. 3B). The intracanalicular pattern was similar in shape 
scribed margins. Non-parallel orientation was observed in 
57.7% of the cases (41/71) and echogenic halo was ob-
served in 21.1% of the cases (15/71). Irregular shape, spic-
ulated margin, or microcalcification was observed in 70.4% 
of the cases (50/71). Microcalcifications on mammogram 
or sonogram were most frequently observed in the clus-
tered microcalcification group than in the other groups 
(p<0.05). On radiology, 16 cases showed calcification, but 
2 cases that belonged to the MHA group did not show mi-
crocalcification on histologic slides even after multiple seri-
al sections.
Histological characteristics
Four distinct histological characteristics were observed 
among 18 cases in the IP group. First, nine of these cases 
exhibited florid-type usual ductal hyperplasia (UDH) (Fig. 
1A). Among the, 4 cases were able to be differentiated from 
a malignant papillary lesion by means of immunohisto-
chemistry for p63 to confirm the presence of myoepithelial 
cells and for ER and CK5/6, which were negative and posi-
tive, respectively, indicative of UDH. Second, eight cases 
showed an entrapped and distorted gland/tubule structure in 
the sclerosing stroma (Fig. 1B). Among these, 2 cases were 
confirmed as benign duct/gland using immunohistochemis-
try for p63. Third, five cases showed slender papillary fronds 
rather than broad papillary fronds (Fig. 1C). Among these 5 
cases, 2 cases were confirmed as benign papillary lesions 
using p63 stain to show myoepithelial cells in the papillary 
core. Lastly, there were two cases of complex sclerosing le-
sions, which showed a central area of stromal fibrosis with 
Fig. 1. Radiological and histological features of the IP group of category 4c or 5 lesions. The papilloma group showed histological features of florid-type usu-
al ductal hyperplasia (A, H&E, ×100), entrapped and distorted glands in the sclerotic stroma (B, H&E, ×100), slender papillary fronds (C, H&E, ×200), and a 
complex sclerosing lesion with a stromal fibrosis zone with entrapped and distorted glands accompanying usual ductal hyperplasia and papilloma (D, H&E, 
×12). IP with slender papillary fronds appeared as an intracystic isoechoic mass with a papillary frond (arrow) on ultrasonogram (E) and a complex scleros-
ing lesion appeared as a 1.0-cm sized irregular-shaped hypoechoic nodule with a spiculated margin and non-parallel orientation (F). The lateral view re-
vealed a spiculated lesion (G). IP, intraductal papilloma.
A
E
B
F
C
G
D
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and parasitic infection, respectively. Among 10 cases in the 
minimal histological alteration (MHA) group, six presented 
with stromal fibrosis (Fig. 5A) and the remaining 4 cases had 
normal breast tissue.
DISCUSSION
In this study, histological analysis was performed on 71 cases 
of benign breast lesions that were categorized as BI-RADS 
4c or 5 breast lesions based on imaging studies. Many studies 
on the differences between the results from imaging studies 
to that of the epithelial component seen in phyllodes tumor. 
Lastly, two cases were complex fibroadenomas showing 
variable cystic structures with apocrine metaplasia and scle-
rosing adenosis (Fig. 3C). Fifteen cases belonged to the in-
flammatory group, which was the most heterogeneous group. 
Among these 15 cases, five showed fat necrosis with calcifi-
cation or xanthogranulomatous inflammation (Fig. 4A). The 
other five cases showed complicated granulomatous lobular 
mastitis (GLM) complicated with abscess (Fig. 4B). Three 
cases were mammary duct ectasia with periductal sclerosis, 
lymphoplasma cell infiltration, and duct distortion (Fig. 4C). 
The remaining two cases involved organizing thrombosis 
Fig. 2. Radiological and histological features of the adenosis and CMC groups of category 4c or 5 lesions. The adenosis group showed sclerosing adenosis 
(A, H&E, ×100), presenting as an irregularly spiculated hypoechoic mass on sonogram (E) and extensive involvement (B, H&E, ×40). CMC was observed in 
the intraluminal space of columnar cell change (C, H&E, ×40) and ossifying-type calcification showed central calcification with a rim of ossifying eosinophil-
ic matrix (D, H&E, ×200), which appeared as echogenic foci (F, arrows) in a spiculated mass on sonogram. CMC, clustered microcalcification.
Fig. 3. Radiological and histological features of the fibroepithelial tumor group of category 4c or 5 lesions. Fibroadenoma demonstrated a sclerosing stromal 
component in the entire tumor lesion (A, H&E, ×40) and an intracanalicular growth pattern of the epithelial component (B, H&E, ×40). An oval microlobulated 
hypoechoic mass was observed on sonogram (D) and a hyperdense mass was observed on mammogram (E). Complex fibroadenoma showed variably sized 
cysts (arrow) and sclerosing adenosis (arrowhead) (C, H&E, ×12). CMC, clustered microcalcification.
A
E
B
F
C D
A
D
B
E
C
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suspicious US features.8,10,12 In the study of Kim, et al.,8 sus-
picious findings were divided into major findings, such as 
irregular shape, spiculated margin and microcalcifications, 
and minor findings, such as round shape, microlobulated/
indistinct/angular margins, nonparallel orientation, duct ex-
tension, complex echogenicity, and posterior shadowing. 
Kim, et al.8 recommended defining the final assessment ac-
cording to the number of major or minor suspicious find-
ings shown; category 5 lesions were defined as lesions 
showing two or more major suspicious features and catego-
ry 4c lesions included lesions with one major suspicious 
feature, with or without minor suspicious features. Addi-
tionally, they advised against basing the final assessment on 
imaging findings alone.10 However, there are still no widely 
accepted guidelines for concluding the final assessment or 
for identifying findings that would cause a lesion to be clas-
sified into a certain category. The first reason for mismatch-
ing between radiology and histology is that clinical infor-
mation such as age, personal history, multiplicity, and 
symptoms should be considered because such information 
may affect radiologist’s decisions for categorization of 
breast lesion.9,13 In this study, nearly 70% of the cases con-
sidered to be of category 4c or 5 had at least one of the ma-
jor suspicious findings suggested by Kim, et al.8 The re-
maining 30% of the category 4c or 5 cases had at least one 
minor suspicious finding, such as symptoms, personal can-
cer history, or patient age. A second potential reason for 
mismatching between radiology and histology guideline is 
and those from tissue examinations have been conducted. 
However, histological analyses of cases identified as false 
positives on imaging analysis have been rarely performed. 
A previous study reported that some cases interpreted as 
category 4, based on US, exhibited benign histological fea-
tures of palpable or nonpalpable lesions.11 The former 
showed fibroadenoma, epithelial and columnar cell hyper-
plasia, and lactating adenoma, while the latter included fi-
broadenoma, epithelial and columnar cell hyperplasia, and 
apocrine metaplasia.11 In addition, the benign cases of cate-
gory 5 lesions in that study were mucocele-like lesions with 
ADH, radial scars, and reactive nodes.11 However, the pre-
vious study did not classify category 4 lesion into 4a, 4b, 
and 4c, as was done in this study. Because category 4a is 
seen more frequently in practice, results for category 4c 
alone might be obscured. The previous study also only in-
vestigated the results of CNB, not CNB and subsequent 
surgical excision, as was done in this study. Therefore, a 
comparison of previous results with the results of this study 
may not be reasonable. In this study, the possibility that a 
malignant lesion was not sampled was probably low, be-
cause we included only the cases diagnosed as benign on 
both CNB and subsequent surgical excision.
Based on a review of previous literature, irregular shape, 
such as spiculated, microlobulated, or angular margin mi-
crocalcifications, nonparallel orientation, echogenic halo, 
ductal extension, hypoechogenicity or complex echogenici-
ty, and posterior shadowing have all been considered as 
Fig. 4. Radiological and histological features of the inflammatory group of category 4c or 5 lesions. The inflammatory group demonstrated fat necrosis with 
calcification (A, H&E, ×100), granulomatous lobular mastitis complicated with abscess (B, H&E, ×100) and mammary duct ectasia showing an ecstatic duct, 
periductal sclerosis and lymphoplasma cell infiltration (C, H&E, ×12), which appeared as an irregular, markedly hypoechoic mass with posterior shadowing 
on sonogram (D). 
Fig. 5. Radiological and histological features of MHA of category 4c or 5 lesions. MHA did not show specific histological findings other than stromal fibrosis 
(A, H&E, ×100). The transverse sonogram showed an irregular microlobulated hypoechoic nodule with posterior shadowing (caliper, B), which was seen as 
an isodense mass on mammogram (arrow in C). MHA, minimal histological alteration.
A
A
B
B
C
C
D
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mammary duct ectasia may mimic cancer on mammogra-
phy.19 In addition, the complex sclerosing lesions in the ra-
dial scar group appeared less organized than typical radial 
scars and could represent a late stage of sclerosing papillo-
ma.20 It has been reported that a radial sclerosing lesion can 
mimic carcinoma on imaging analysis.21,22 Third, there are 
the histological features that should be differentiated from 
malignancy. Sclerosing adenosis in the adenosis group 
showed compressed and distorted glands by stromal prolif-
eration, mimicking invasive ductal carcinoma (IDC). In 
such situations, immunohistochemical staining with mark-
ers such as p63 to detect myoepithelial cells can aid in dif-
ferential diagnosis.20 In this study, IP with florid-type UDH 
was presented in the IP group. When IP involves an area of 
ductal cell proliferation, such as florid-type UDH, IP with 
ADH or IP with ductal carcinoma in situ (DCIS) becomes 
the main differential diagnosis.20 For papillary lesions that 
are difficult to diagnose, it is necessary to examine the ex-
pression patterns of cytokeratin 5/6 and ER in the ductal 
cell proliferation area, which are helpful for differential di-
agnosis. Cytokeratin 5/6 is expressed and ER is not ex-
pressed in IP with florid-type UDH, while cytokeratin 5/6 is 
not expressed and ER is expressed in IP with ADH or IP 
with DCIS.23-26 As, histological features of entrapped and 
distorted glands in the sclerotic stroma in the IP group are 
similar to those in IDC, the use of a myoepithelial cell 
marker such as p63 can aid in differential diagnosis, as in 
the case of sclerosing adenosis.20 Slender papillary fronds 
were observed in the IP group in this study. In general, be-
nign papillomas have wider papillary fronds than papillary 
carcinomas.20 The confirmation of continuous myoepitheli-
al cells in the papillary core by immunohistochemical stain-
ing such as p63 helps when a benign papilloma shows slen-
der papillary fronds.25
In this study, OTC was observed in 5 of 10 cases of CMC. 
OTC does not actually contain osteocytes or osteoblasts, 
but is morphologically similar to osseous tissue on H&E 
stained slides.27,28 OTC can be found across the entire spec-
trum of proliferative duct lesions. However, studies of the 
radiological appearance of OTC are rare. Further study is 
needed to clarify two conflicting opinions: 1) OTC cannot 
be differentiated from other types of calcification,27 and 2) 
OTC appears as dense cluster on radiological analysis.28
In conclusion, based on our analysis of 71 cases that were 
categorized as 4c or 5 on imaging analysis but were then 
diagnosed as benign on histological examination, we found 
that IP was the most commonly identified lesion, followed 
interobserver variability, which has a known kappa value of 
0.28-0.80 for final assessments and lexicons.14,15 The imag-
ing findings were retrospectively reviewed by one experi-
enced radiologist. The only way to verify the propriety of 
the final assessment is performing a medical audit on each 
radiologist and each imaging center, which was not per-
formed in this study. The appropriate positive predictive 
value was considered to be greater than 50% for category 
4c and greater than 95% for category 5, and the percentage 
of benign lesions actually classified into categories 4c and 5 
in this study was around 7% (71/2385), which is within the 
previously reported range.14,15 
In this study, cases were classified into six histological 
groups (adenosis, CMC, FET, inflammatory, IP and MHA), 
exhibiting three characteristic histological features. First 
was a sclerosing or fibrosing feature that we observed in the 
following lesions: sclerosing adenosis in the adenosis group, 
sclerosis of the stromal component of fibroadenomas and 
sclerosing adenosis of complex fibroadenomas in the FET 
group, periductal sclerosis of mammary duct ectasia in the 
inflammatory group, entrapped/distorted glands of sclerotic 
stroma in the IP group, a sclerotic stromal zone of complex 
sclerosing lesions in the IP group, and stromal fibrosis in 
the MHA group. Unfortunately, there have not been enough 
studies to examine how sclerosis of the breast impacts US 
imaging. In a previous study, images of cases diagnosed as 
focal fibrosis on US-guided CNB originally belonged to cat-
egory 3 or category 4a.16 A comparison of this previous 
study with our study is not appropriate, as sclerosis in the 
previous study had diffuse involvement rather than focal in-
volvement and was also accompanied by underlying breast 
disease. Such sclerosis could distort underlying breast le-
sions or structures, resulting in suspicious lesions on imag-
ing studies. The second histological feature included com-
plex or complicated features that were found in the 
following lesions: complex fibroadenoma in the FET 
group, complicated GLM with abscess and mammary duct 
ectasia (ectatic duct, periductal sclerosis, lymphoplasma 
cell infiltration) in the inflammatory group, and complex 
sclerosing lesion in the IP group. Such histologically com-
plex lesions could be interpreted as malignancies on imag-
ing studies. The image findings for complex fibroadenoma 
include cystic changes or calcifications rather than typical fi-
broadenomas with elliptical, well-defined margins.17 How-
ever, it has been reported that GLMs appear as suspicious 
cancers on mammography and “multiple clustered, often 
contiguous tubular hypoechoic lesions” on US.18 Also, 
Min Jung Kim, et al.
Yonsei Med J   http://www.eymj.org   Volume 53   Number 6   November 20121210
and outcome. Radiology 2008;248:773-81.
12. Stavros AT, Thickman D, Rapp CL, Dennis MA, Parker SH, Sis-
ney GA. Solid breast nodules: use of sonography to distinguish be-
tween benign and malignant lesions. Radiology 1995;196:123-34.
13. Baek SE, Kim MJ, Kim EK, Youk JH, Lee HJ, Son EJ. Effect of 
clinical information on diagnostic performance in breast sonogra-
phy. J Ultrasound Med 2009;28:1349-56.
14. Lee HJ, Kim EK, Kim MJ, Youk JH, Lee JY, Kang DR, et al. Ob-
server variability of Breast Imaging Reporting and Data System 
(BI-RADS) for breast ultrasound. Eur J Radiol 2008;65:293-8. 
15. Park CS, Lee JH, Yim HW, Kang BJ, Kim HS, Jung JI, et al. Ob-
server agreement using the ACR Breast Imaging Reporting and 
Data System (BI-RADS)-ultrasound, First Edition (2003). Korean 
J Radiol 2007;8:397-402.
16. You JK, Kim EK, Kwak JY, Kim MJ, Oh KK, Park BW, et al. Fo-
cal fibrosis of the breast diagnosed by a sonographically guided 
core biopsy of nonpalpable lesions: imaging findings and clinical 
relevance. J Ultrasound Med 2005;24:1377-84.
17. Stavros A. Breast Ultrasound. Philadelphia: Lippincott Williams 
& Wilkins; 2004.
18. Han BK, Choe YH, Park JM, Moon WK, Ko YH, Yang JH, et al. 
Granulomatous mastitis: mammographic and sonographic appear-
ances. AJR Am J Roentgenol 1999;173:317-20.
19. Sweeney DJ, Wylie EJ. Mammographic appearances of mammary 
duct ectasia that mimic carcinoma in a screening programme. 
Australas Radiol 1995;39:18-23.
20. Schnitt SJ, Collins LC. Biopsy Interpretation of the Breast. 1st ed. 
New York: Lippincott Williams & Wilkins; 2009.
21. Mitnick JS, Vazquez MF, Harris MN, Roses DF. Differentiation of 
radial scar from scirrhous carcinoma of the breast: mammograph-
ic-pathologic correlation. Radiology 1989;173:697-700.
22. Adler DD, Helvie MA, Oberman HA, Ikeda DM, Bhan AO. Ra-
dial sclerosing lesion of the breast: mammographic features. Radi-
ology 1990;176:737-40.
23. Shah VI, Flowers CI, Douglas-Jones AG, Dallimore NS, Rashid 
M. Immunohistochemistry increases the accuracy of diagnosis of 
benign papillary lesions in breast core needle biopsy specimens. 
Histopathology 2006;48:683-91.
24. Ichihara S, Fujimoto T, Hashimoto K, Moritani S, Hasegawa M, 
Yokoi T. Double immunostaining with p63 and high-molecular-
weight cytokeratins distinguishes borderline papillary lesions of 
the breast. Pathol Int 2007;57:126-32.
25. Tse GM, Tan PH, Lui PC, Gilks CB, Poon CS, Ma TK, et al. The 
role of immunohistochemistry for smooth-muscle actin, p63, 
CD10 and cytokeratin 14 in the differential diagnosis of papillary 
lesions of the breast. J Clin Pathol 2007;60:315-20. 
26. Grin A, O’Malley FP, Mulligan AM. Cytokeratin 5 and estrogen 
receptor immunohistochemistry as a useful adjunct in identifying 
atypical papillary lesions on breast needle core biopsy. Am J Surg 
Pathol 2009;33:1615-23.
27. Resetkova E, Hoda SA. “Ossifying-type” mammary calcifica-
tions. Arch Pathol Lab Med 2002;126:995-6.
28. Hoda SA, Gopalan A. Mammary calcifications of the ossifying 
type. Breast J 2003;9:129-30.
by the inflammatory group, FET, CMC MHA, and adeno-
sis, in that order. The distinguishing histological character-
istics of these six groups were sclerosis and architectural 
complexity indicative of malignancy. 
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